Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

PTC Therapeutics Inc

PTC Therapeutics Inc

PTCT · NASDAQ
PTCT · NASDAQ
68.03
USD-7.19-9.57%

Latest News

    @Reuters
    Reuters

    PTC Therapeutics discontinues development of ALS drug after trial failure https://t.co/GxuiNIBjDV https://t.co/SKpegtFZoL

      @Reuters
      Reuters

      Europe to withdraw PTC Therapeutics' rare muscle disorder drug https://t.co/eVsjAsOJdj https://t.co/gxh9aoT9Dh

        MarketWatch

        PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion

          @Barchart
          Barchart

          4 Stock Market Morning Movers: $KSS $URBN $PTCT $PLCE Check out the Details 👇 https://t.co/gT2g7NNAVr

          Analysts Recommendations

          Bullish

          Buy

          Strong Buy

          Buy

          Hold

          Sell

          Strong Sell

          Day Range

          64.57USD
          73.72USD

          52 Week Range

          43.17USD
          90.87USD

          Market Cap

          6.18BUSD

          lock-imagelock-image

          Get Full Access with Profit PRO

          See which Billionaires own this investment

          About

          General Information

          Type

          Common Stock

          Exchange

          NASDAQ

          Currency Code

          USD

          Currency Name

          US Dollar

          Country Name

          USA

          Country ISO

          US

          ISIN

          US69366J2006

          CUSIP

          69366J200

          Sector

          Healthcare

          Industry

          Biotechnology

          Fiscal Year End

          December

          IPO date

          -

          Updated At

          -

          Highlights

          PE Ratio

          -

          PEG Ratio

          0.81

          Book Value

          -2.18

          Dividend Share

          -

          Dividend Yield

          -

          Earnings Share

          -2.54

          Wall Street Target Price

          96.07

          EPS Estimate Current Year

          1.32

          EPS Estimate Next Year

          2.74

          EPS Estimate Current Quarter

          -0.44

          EPS Estimate Next Quarter

          -0.46

          Most Recent Quarter

          -

          Profitability

          Revenue TTM

          827,110,016

          Gross Profit TTM

          316,982,016

          EBITDA

          -20,901,000

          Profit Margin

          -22.58%

          Return On Assets TTM

          -1.54%

          Return On Equity TTM

          -7740.12%

          Revenue Per Share TTM

          10.257

          Qtly Revenue Growth YOY

          -76.80%

          Diluted Eps TTM

          -2.54

          Qtly Earnings Growth YOY

          0.00%

          Valuation

          Trailing PE

          0.00

          Forward PE

          38

          Price Sales TTM

          7.5738

          Price Book MRQ

          1743.2734

          Enterprise Value Revenue

          5

          Enterprise Value EBITDA

          6

          Peers analysis

          • UCB SA
            UCBJFUCB SA

            269.66

            3.88%
          • Regeneron Pharmaceuticals Inc
            REGNRegeneron Pharmaceuticals Inc

            760.00

            3.03%
          • UCB SA ADR
            UCBJYUCB SA ADR

            128.41

            2.84%
          • argenx SE
            ARGNFargenx SE

            865.00

            0.00%
          • CSL Ltd
            CSLLYCSL Ltd

            21.64

            -4.71%
          • argenx NV ADR
            ARGXargenx NV ADR

            853.82

            -2.26%
          • Revolution Medicines Inc
            RVMDRevolution Medicines Inc

            187.48

            -2.14%
          • CSL Limited
            CMXHFCSL Limited

            87.86

            -1.21%
          • Vertex Pharmaceuticals Inc
            VRTXVertex Pharmaceuticals Inc

            476.99

            -0.98%
          • Alnylam Pharmaceuticals Inc
            ALNYAlnylam Pharmaceuticals Inc

            204.11

            -0.83%
          XM

          Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

          Trade with a Trusted, Award-Winning Broker.

          Trading involves risk. The value of investments may go up or down. Trade responsibly.

          FAQs

          What is PTC Therapeutics stock price today?

          What is PTC Therapeutics stock ticker?

          Is PTCT stock price going up?

          What is the analyst recommendation for PTCT?

          What is PTCT market cap?

          Does PTCT release financial reports?

          When is PTCT next earnings date?

          What were PTCT Earnings for the last quarter?

          What was PTCT Revenue for the last quarter?

          What was PTCT Net Income for the last quarter?

          Does PTCT pay dividends?

          How many employees does PTCT have?

          What is PTCT EBITDA?

          How to buy PTCT stocks?

          Should I invest in PTCT stock?